CLINICAL-SIGNIFICANCE OF THE RELATIONSHIP BETWEEN O-METHYLDOPA LEVELS AND LEVODOPA INTAKE

被引：40

作者：

CEDARBAUM, JM ^{[1
]}

KUTT, H ^{[1
]}

MCDOWELL, FH ^{[1
]}

机构：

[1] CORNELL UNIV,COLL MED,WHITE PLAINS,NY 10605

来源：

NEUROLOGY | 1988年 / 38卷 / 04期

关键词：

D O I：

10.1212/WNL.38.4.533

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：533 / 536

页数：4

共 23 条

[1]

CALNE DB, 1972, CLIN PHARMACOL THER, V14, P386

[2] CONTROLLED-RELEASE LEVODOPA CARBIDOPA .1. SINEMET CR3 TREATMENT OF RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE [J].

CEDARBAUM, JM ;

BRECK, L ;

KUTT, H ;

MCDOWELL, FH .

NEUROLOGY, 1987, 37 (02) :233-241

[3] CONTROLLED-RELEASE LEVODOPA CARBIDOPA .2. SINEMET CR4 TREATMENT OF RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE [J].

CEDARBAUM, JM ;

BRECK, L ;

KUTT, H ;

MCDOWELL, FH .

NEUROLOGY, 1987, 37 (10) :1607-1612

[4]

CEDARBAUM JM, 1987, J CHROMATOGR, V410, P393

[5]

DURSO R, 1985, Neurology, V35, P223

[6] 3-0-METHYLDOPA AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE [J].

FABBRINI, G ;

JUNCOS, JL ;

MOURADIAN, MM ;

SERRATI, C ;

CHASE, TN .

NEUROLOGY, 1987, 37 (05) :856-859

[7] IN-VITRO DECARBOXYLATION OF NEW PHENYLALANINE DERIVATIVES [J].

FERRINI, R ;

GLASSER, A .

BIOCHEMICAL PHARMACOLOGY, 1964, 13 (05) :798-&

[8]

FEUERSTEIN C, 1977, ACTA NEUROL SCAND, V56, P79

[9]

GERVAS JJ, 1983, NEUROLOGY, V33, P278, DOI 10.1212/WNL.33.3.278

[10]

KURUMA I, 1971, CLIN PHARMACOL THER, V12, P678

← 1 2 3 →